As they say in Vegas when you lose, "Thanks for th
Post# of 148168
I think you're wrong, people will NOT be asking "what is leronlimab" or anything else about it. If you read about something that didn't work and shows no use, do you really delve deep into it? Of course not, what would be the point?
We all want to believe that the FDA did this to cover their butts, however I don't think so. If the FDA knows that India will kill leronlimab's chances there with this piece, then THAT is why they did it.
The FDA statement does slam CYDY for not putting together well-designed trials, it seems. The buck stops with someone at CYDY...that is how business works.